While conducting research on bispecific antibody drugs, it is almost impossible not to come across some references to CD3. To accelerate the research and development of bispecific antibodies, ACROBiosystems has developed a series of homogeneous CD3d/CD3e and CD3?/CD3e proteins with high bioactivity.
Customer data suggests that bispecific antibody products from ACROBiosystems can be used in applications of clinical pharmacokinetics, therapeutic antibody screening, identification, characterization, etc. |